Gujarat Themis Biosyn Ltd. Publishes Newspaper Advertisement for Postal Ballot Notice
Gujarat Themis Biosyn Limited published a newspaper notice for its postal ballot on March 19, 2026. Members will vote on re-appointing Mrs. Kirandeep Madan and approving related party transactions with Themis Medicare Limited. E-voting is open from March 19 to April 17, 2026.
This is a standard procedural announcement related to corporate governance and shareholder voting, which typically has a minimal impact on the company's stock price.
The announcement is a routine regulatory filing regarding a postal ballot and does not contain any new financial information or significant business developments that would impact the company's valuation.
Gujarat Themis Biosyn Limited has published a newspaper advertisement regarding the Notice of Postal Ballot in the 'Western Times' (English and Gujarati editions) on Thursday, 19th March, 2026. This notice is issued in accordance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company is seeking approval from its members via postal ballot through remote electronic voting (e-voting) for two resolutions: a Special Resolution for the re-appointment of Mrs. Kirandeep Madan as Non-Executive Woman Independent Director and an Ordinary Resolution for the approval of Material Related Party Transactions with Themis Medicare Limited (TML).
The cut-off date for determining voting eligibility was Friday, 13th March, 2026. The remote e-voting period commenced on Thursday, 19th March, 2026, at 9:00 a.m. (IST) and will conclude on Friday, 17th April, 2026, at 05:00 p.m. (IST). Mr. Ketan R. Shirwadkar has been appointed as the Scrutinizer for the e-voting process. The results of the postal ballot are expected to be announced by Tuesday, 21st April, 2026.
What to do with a filing like this
Gujarat Themis Biosyn Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Themis Biosyn Limited. Read the original for the full detail.